Biomarker Trio Shows Promise for Monitoring CKD

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The type of renal replacement therapy, duration of dialysis, and disease aetiology and stage significantly affect levels of renalase, dopamine, and norepinephrine in patients with CKD.
Medscape News UK